{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:58:40Z","timestamp":1787320720643,"version":"build-2736575974"},"reference-count":147,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.ackd.2021.11.003","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T19:31:55Z","timestamp":1657308715000},"page":"103-115.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Kidney Disease Following Hematopoietic Stem Cell Transplantation"],"prefix":"10.1053","volume":"29","author":[{"given":"Ala","family":"Abudayyeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimda","family":"Wanchoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1053\/j.ackd.2021.11.003_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"9134","key":"10.1053\/j.ackd.2021.11.003_bib2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(98)03030-X","article-title":"Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"352","author":"Gratwohl","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib3","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current Use of and Trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib4","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"9249","key":"10.1053\/j.ackd.2021.11.003_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0140-6736(00)03561-3","article-title":"Renal failure after bone-marrow transplantation","volume":"357","author":"Cohen","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2004.11.013","article-title":"Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation","volume":"45","author":"Parikh","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bmt.2009.99","article-title":"A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT","volume":"45","author":"Liu","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bmt.2009.377","article-title":"A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT","volume":"45","author":"Ando","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bmt.1705412","article-title":"Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation","volume":"38","author":"Caliskan","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hon.2141","article-title":"A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Ataei","year":"2015","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5414\/CN107280","article-title":"Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience","volume":"77","author":"Kang","year":"2012","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib12","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2215\/CJN.19801220","article-title":"Acute kidney injury in the modern Era of allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Abramson","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/bmt.2015.357","article-title":"Acute kidney injury in HCT: an update","volume":"51","author":"Lopes","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2215\/CJN.01840214","article-title":"Urinary elafin and kidney injury in hematopoietic cell transplant recipients","volume":"10","author":"Hingorani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib15","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.bbmt.2014.07.008","article-title":"Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation","volume":"20","author":"Laskin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ejh.13101","article-title":"Autologous peripheral blood stem cell transplantation in dialysis-dependent multiple myeloma patients-DAUTOS Study of the Polish Myeloma Study Group","volume":"101","author":"Waszczuk-Gajda","year":"2018","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0272-6386(04)00822-4","article-title":"Reversal of dialysis-dependent renal failure in light-chain deposition disease by autologous peripheral blood stem cell transplantation","volume":"44","author":"Firkin","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/bmt.2017.198","article-title":"Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency:\u00a0a center for international blood and marrow transplant research analysis","volume":"52","author":"Mahindra","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-018-0122-8","article-title":"Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC","volume":"53","author":"Augeul-Meunier","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1186\/s12885-018-4926-0","article-title":"Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study","volume":"18","author":"Antlanger","year":"2018","journal-title":"Bmc Cancer"},{"issue":"23","key":"10.1053\/j.ackd.2021.11.003_bib21","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.1998.1998","article-title":"Melphalan 200 Mg\/m2 in patients with renal impairment is associated with increased short term toxicity but improved response and longer treatment-free survival","volume":"126","author":"Sweiss","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0609.2005.00446.x","article-title":"Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure","volume":"75","author":"Knudsen","year":"2005","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2141.2001.03033.x","article-title":"Results of autologous stem cell transplant in multiple myeloma patients with renal failure","volume":"114","author":"Badros","year":"2001","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.ackd.2021.11.003_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1705627","article-title":"Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma","volume":"39","author":"Gertz","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2014.226","article-title":"Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure","volume":"50","author":"St Bernard","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.ackd.2021.11.003_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bmt.1704948","article-title":"Melphalan 200 mg\/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival","volume":"35","author":"Carlson","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2021.11.003_bib27","first-page":"1555","article-title":"The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure","volume":"91","author":"Raab","year":"2006","journal-title":"Haematologica"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clml.2015.03.003","article-title":"Autologous hematopoietic stem cell transplantation in dialysis-dependent myeloma patients","volume":"15","author":"El Fakih","year":"2015","journal-title":"Cl Lymph Myelom Leuk"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbmt.2009.03.021","article-title":"Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma","volume":"15","author":"Parikh","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib30","first-page":"182","article-title":"Impact of autologous stem cell transplantation on blood Pressure and renal function in multiple myeloma patients","volume":"109","author":"Balsam","year":"2017","journal-title":"J Natl Med Assoc"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbmt.2017.03.006","article-title":"Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies","volume":"23","author":"Barker","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib32","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1182\/blood-2004-03-1001","article-title":"Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies","volume":"104","author":"Takahashi","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib33","doi-asserted-by":"crossref","first-page":"e12632","DOI":"10.1111\/tid.12632","article-title":"Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients","volume":"19","author":"Abudayyeh","year":"2017","journal-title":"Transplant Infect Dis"},{"issue":"11","key":"10.1053\/j.ackd.2021.11.003_bib34","first-page":"476b","article-title":"CMV infection and disease in adult patients undergoing unrelated donor cord blood transplantation (UD-CBT)","volume":"102","author":"Sanz","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/tid.12038","article-title":"Acute kidney injury after myeloablative cord blood transplantation in adults: the efficacy of strict monitoring of vancomycin serum trough concentrations","volume":"15","author":"Mae","year":"2013","journal-title":"Transplant Infect Dis"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/10428190701824577","article-title":"Early renal injury after myeloablative cord blood transplantation in adults","volume":"49","author":"Mae","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbmt.2013.02.018","article-title":"Ex\u00a0vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission","volume":"19","author":"Bayraktar","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/bmt.2016.343","article-title":"Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants","volume":"52","author":"Glezerman","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bmt.1703855","article-title":"Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria","volume":"31","author":"Maiolino","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bmt.1703324","article-title":"Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"29","author":"Oyama","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib42","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bbmt.2019.04.022","article-title":"Reduction in nephrotoxic Antimicrobial exposure decreases associated acute kidney injury in pediatric hematopoietic stem cell transplant patients","volume":"25","author":"Benoit","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1523-1755.2005.00078.x","article-title":"Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors","volume":"67","author":"Hingorani","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.kint.2016.03.031","article-title":"A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury","volume":"90","author":"Goldstein","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2215\/CJN.08110910","article-title":"Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children","volume":"6","author":"Moffett","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705573","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplant","volume":"39","author":"Hingorani","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9323","key":"10.1053\/j.ackd.2021.11.003_bib48","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5000055","article-title":"Acute renal failure in hematopoietic cell transplantation","volume":"69","author":"Parikh","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib50","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/cncr.20613","article-title":"Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management","volume":"101","author":"Couriel","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199708270-00001","article-title":"Cytokine cascades in acute graft-versus-host disease","volume":"64","author":"Krenger","year":"1997","journal-title":"Transplantation"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib52","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2008-07-169342","article-title":"Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation","volume":"112","author":"Cutler","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.ackd.2021.11.003_bib53","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","article-title":"Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation","volume":"40","author":"Cheuk","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib56","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.2042-7158.1995.tb05789.x","article-title":"Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity","volume":"47","author":"Schr\u00f6der","year":"1995","journal-title":"J Pharm Pharmacol"},{"issue":"26","key":"10.1053\/j.ackd.2021.11.003_bib58","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.ackd.2021.11.003_bib59","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMra1404711","article-title":"Renal complications of hematopoietic-cell transplantation","volume":"374","author":"Hingorani","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib60","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib61","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/ajt.13635","article-title":"Symptomatic BK virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients","volume":"16","author":"Abudayyeh","year":"2016","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/bloodadvances.2019000802","article-title":"Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation","volume":"4","author":"Imlay","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2014.01.014","article-title":"BK virus disease after allogeneic stem cell transplantation: a cohort analysis","volume":"20","author":"Rorije","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib64","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.TP.0000122421.71556.71","article-title":"Adenovirus nephritis in hematopoietic stem-cell transplantation","volume":"77","author":"Bruno","year":"2004","journal-title":"Transplantation"},{"issue":"31","key":"10.1053\/j.ackd.2021.11.003_bib65","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-Shelf virus-specific T cells to treat BK virus, human Herpesvirus 6, Cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1053\/j.ackd.2021.11.003_bib66","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1200\/JCO.20.02608","article-title":"Third-party BK virus-specific cytotoxic T lymphocyte therapy for hemorrhagic cystitis following Allotransplantation","volume":"39","author":"Olson","year":"2021","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib67","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.bbmt.2017.08.021","article-title":"Impact of fluid overload as new toxicity category on hematopoietic stem cell transplantation outcomes","volume":"23","author":"Rondon","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib68","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/ndt\/gfh720","article-title":"Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation","volume":"20","author":"Schrier","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1523-1755.2002.00455.x","article-title":"Renal dysfunction in allogeneic hematopoietic cell transplantation","volume":"62","author":"Parikh","year":"2002","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib70","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/01.ASN.0000129981.50357.1C","article-title":"Acute renal failure after nonmyeloablative hematopoietic cell transplantation","volume":"15","author":"Parikh","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib71","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1523-1755.2005.00301.x","article-title":"Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant","volume":"67","author":"Parikh","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib72","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12185-018-2536-x","article-title":"Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation","volume":"108","author":"Nakamura","year":"2018","journal-title":"Int J Hematol"},{"issue":"suppl 1","key":"10.1053\/j.ackd.2021.11.003_bib73","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1093\/ndt\/gfy104.FP145","article-title":"Acute kidney injury developing in the early period in the patients undergoing autolog and allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Cekdemir","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1704144","article-title":"Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients","volume":"32","author":"Hahn","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib75","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1053\/j.ackd.2021.11.003_bib76","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: a systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib77","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment","volume":"17","author":"Hingorani","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"0","key":"10.1053\/j.ackd.2021.11.003_bib78","article-title":"Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation","volume":"0","author":"Lugthart","year":"2021","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2017.08.016","article-title":"Chronic kidney disease in long-term survivors after allogeneic hematopoietic stem cell transplantation: retrospective analysis at a single institute","volume":"23","author":"Jo","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib80","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ndt\/gfp485","article-title":"Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors","volume":"25","author":"Ando","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib81","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41409-020-0843-3","article-title":"Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis","volume":"55","author":"Gutierrez-Garcia","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib82","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jtct.2021.02.030","article-title":"Impact of Pretransplantation renal dysfunction on outcomes after allogeneic hematopoietic cell transplantation","volume":"27","author":"Farhadfar","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib83","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2215\/CJN.10630917","article-title":"Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: a Prospective cohort study","volume":"13","author":"Hingorani","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib84","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2010.09.001","article-title":"Onco-nephrology: kidney disease in the cancer patient: introduction","volume":"30","author":"Humphreys","year":"2010","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib85","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bmt.2013.197","article-title":"Urinary cytokines after HCT: evidence for renal inflammation in the pathogenesis of proteinuria and kidney disease","volume":"49","author":"Hingorani","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib86","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib88","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2014.17","article-title":"Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus","volume":"49","author":"Labrador","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib89","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib90","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib91","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib92","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1440-1797.2007.00915.x","article-title":"Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation","volume":"13","author":"Chan","year":"2008","journal-title":"Nephrology"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib93","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib94","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.ackd.2021.11.003_bib95","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib96","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02983218","article-title":"Clinical significance of fragmented red cells after allogeneic bone marrow transplantation","volume":"77","author":"Kanamori","year":"2003","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib97","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2018.06.013","article-title":"Emerging Concepts in hematopoietic stem cell transplantation-associated renal thrombotic microangiopathy and Prospects for new treatments","volume":"72","author":"Wanchoo","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bmt.1705410","article-title":"Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation","volume":"38","author":"Min","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib99","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib100","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib101","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1053\/j.ackd.2021.11.003_bib102","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib104","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib106","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib107","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1537-2995.2008.02030.x","article-title":"Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008","volume":"49","author":"Nguyen","year":"2009","journal-title":"Transfusion"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib108","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1093\/ndt\/gfn173","article-title":"The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura","volume":"23","author":"Thachil","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib109","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/bmt.2017.207","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies","volume":"53","author":"Khosla","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.ackd.2021.11.003_bib111","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/bmt.2008.25","article-title":"Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura","volume":"41","author":"Carella","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"1292","key":"10.1053\/j.ackd.2021.11.003_bib112","first-page":"72","article-title":"Successful treatment of transplant-associated microangiopathy with rituximab","volume":"122","author":"Marr","year":"2009","journal-title":"N Z Med J"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib113","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1111\/j.1399-3046.2010.01408.x","article-title":"Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation","volume":"16","author":"Jodele","year":"2012","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib114","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC","volume":"99","author":"de Fontbrune","year":"2015","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1076029615599439","article-title":"Eculizumab in transplant-associated thrombotic microangiopathy","volume":"23","author":"Dhakal","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"13","key":"10.1053\/j.ackd.2021.11.003_bib116","first-page":"1049","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib117","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ejh.13127","article-title":"Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients","volume":"101","author":"Rudoni","year":"2018","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib118","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib119","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00007890-199006000-00013","article-title":"Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients","volume":"49","author":"Dieterle","year":"1990","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib121","doi-asserted-by":"crossref","first-page":"e13633","DOI":"10.1111\/ctr.13633","article-title":"Amlodipine and calcineurin inhibitor-induced nephrotoxicity following allogeneic hematopoietic stem cell transplant","volume":"33","author":"Jensen","year":"2019","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2006.05999.x","article-title":"Nephrotic syndrome after non-myeloablative stem cell transplantation","volume":"132","author":"Ruiz-Arguelles","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib123","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2005.05728.x","article-title":"Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation","volume":"131","author":"Srinivasan","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib124","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1532\/IJH97.05074","article-title":"Nephrotic syndrome with extensive mesangiolysis as a clinical manifestation of chronic graft-versus-host disease (GVHD)","volume":"82","author":"Kawakami","year":"2005","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1705446","article-title":"Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"38","author":"Reddy","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib127","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/ndt\/gfq645","article-title":"The role of graft-versus-host disease in haematopoietic cell transplantation-associated glomerular disease","volume":"26","author":"Hu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5414\/CNP67005","article-title":"Favorable long-term outcome of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Kemper","year":"2007","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5414\/CNP58231","article-title":"Diffuse proliferative glomerulonephritis after bone marrow transplantation","volume":"58","author":"Suehiro","year":"2002","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI11088","article-title":"Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes","volume":"106","author":"Murphy","year":"2000","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ackd.2021.11.003_bib131","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.kint.2020.12.005","article-title":"The Case | Proteinuria in a patient with hematopoietic stem cell transplantation","volume":"99","author":"Bonilla","year":"2021","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2021.11.003_bib132","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.ekir.2021.04.033","article-title":"NELL1-Associated membranous Glomerulopathy after hematopoietic stem cell transplantation","volume":"6","author":"Kudose","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.ackd.2021.11.003_bib133","article-title":"Membranous nephropathy with extensive tubular basement membrane deposits following allogeneic hematopoietic cell transplant: a report of 5 cases","author":"Nasr","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib134","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1871525711311010011","article-title":"The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature","volume":"11","author":"Niscola","year":"2013","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/imj.13098","article-title":"Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantation","volume":"46","author":"Wong","year":"2016","journal-title":"Intern Med J"},{"issue":"9","key":"10.1053\/j.ackd.2021.11.003_bib136","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","article-title":"Significant increase in end-stage renal disease after hematopoietic stem cell transplantation","volume":"39","author":"Cohen","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib137","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/10428194.2016.1211280","article-title":"Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience","volume":"58","author":"Shadman","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib138","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41409-019-0697-8","article-title":"Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras","volume":"55","author":"Li","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib139","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1704440","article-title":"Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant","volume":"33","author":"Lee","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/bcp.12906","article-title":"High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation","volume":"82","author":"Nath","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1053\/j.ackd.2021.11.003_bib141","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbmt.2017.08.031","article-title":"High-dose melphalan and stem cell transplantation in patients on dialysis due to Immunoglobulin light-chain Amyloidosis and monoclonal Immunoglobulin deposition disease","volume":"24","author":"Batalini","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ackd.2021.11.003_bib142","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/j.clml.2019.11.004","article-title":"Salvage chemotherapy followed by autologous stem-cell transplantation using targeted busulfan for refractory diffuse large B-cell lymphoma with dialysis-dependent end-stage renal disease","volume":"20","author":"Morita","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1053\/j.ackd.2021.11.003_bib143","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","article-title":"Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression","volume":"13","author":"Butcher","year":"1999","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib144","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1034\/j.1600-6143.2003.00015.x","article-title":"Outcomes of renal transplantation following bone marrow transplantation","volume":"3","author":"Hamawi","year":"2003","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2021.11.003_bib145","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1600-6143.2010.03187.x","article-title":"Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT","volume":"10","author":"Koenecke","year":"2010","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2021.11.003_bib146","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/ajt.15240","article-title":"Solid organ transplantation after hematopoietic stem cell transplantation in childhood: a multicentric retrospective survey","volume":"19","author":"Faraci","year":"2019","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2021.11.003_bib147","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559521001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559521001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:05:59Z","timestamp":1761548759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559521001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1548559521001452"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2021.11.003","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Disease Following Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2021.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}